Celularity Inc. logo

Celularity Inc.

NASDAQ:CELU

Overview | Financials
Company Name Celularity Inc.
Symbol CELU
Currency USD
Price 2.8
Market Cap 61,556,880
Dividend Yield 0%
52-week-range 1.59 - 7.97
Industry Biotechnology
Sector Healthcare
CEO Dr. Robert Joseph Hariri M.D., Ph.D.
Website https://www.celularity.com

An error occurred while fetching data.

About Celularity Inc.

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial

Related Stocks

Silk Road Medical, Inc logo

Silk Road Medical, Inc

SILK

27.5 USD

Instil Bio, Inc. logo

Instil Bio, Inc.

TIL

84.52 USD

Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

ALLO

2.96 USD

Cassava Sciences, Inc. logo

Cassava Sciences, Inc.

SAVA

28.12 USD

SomaLogic, Inc. logo

SomaLogic, Inc.

SLGC

2.1 USD

Innoviva, Inc. logo

Innoviva, Inc.

INVA

19.81 USD

Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation

ADPT

4.61 USD

MannKind Corporation logo

MannKind Corporation

MNKD

6.27 USD

Financials

Numbers are in millions USD

Numbers are in millions USD